+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

AI in Inflammatory Bowel Disease Market 2025-2029

  • PDF Icon

    Report

  • 225 Pages
  • August 2025
  • Region: Global
  • TechNavio
  • ID: 6156382
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global AI in inflammatory bowel disease market is forecasted to grow by USD 312.1 million during 2024-2029, accelerating at a CAGR of 33.3% during the forecast period. The report on the global AI in inflammatory bowel disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative for enhanced diagnostic accuracy and personalized treatment pathways, rapid advancements in AI capabilities and proliferation of big data in healthcare, and surging investment and strategic industry collaborations fueling innovation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The global AI in inflammatory bowel disease market is segmented as below:

By Disease Type

  • Ulcerative colitis
  • Crohns disease

By Application

  • Diagnosis assistance
  • Treatment optimization
  • Disease monitoring

By End-user

  • Hospitals
  • Specialty clinics
  • Diagnostic laboratories
  • Academic and research institutes

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa
This study identifies the evolution from diagnostic augmentation to predictive and prognostic intelligence as one of the prime reasons driving the global AI in inflammatory bowel disease market growth during the next few years. Also, ascendance of AI as engine for novel drug discovery and therapeutic development and strategic shift towards enterprise-level integration and demonstrable workflow efficiency will lead to sizable demand in the market.

The report on the global AI in inflammatory bowel disease market covers the following areas:

  • Global AI In Inflammatory Bowel Disease Market sizing
  • Global AI In Inflammatory Bowel Disease Market forecast
  • Global AI In Inflammatory Bowel Disease Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global AI in inflammatory bowel disease market vendors that include AbbVie Inc., Bayer AG, BenevolentAI, Dova Health Intelligence Inc., F. Hoffmann La Roche Ltd., Insilico Medicine, International Business Machines Corp., Olympus Corp., Owkin Inc., PathAI Inc., Pfizer Inc., Siemens Healthineers AG, SingHealth Group., Takeda Pharmaceutical Co. Ltd., and Tempus Labs Inc. Also, the global AI in inflammatory bowel disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Disease Type
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
5.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
6 Market Segmentation by Disease Type
6.1 Market segments
Chart on Disease Type - Market share 2024-2029 (%)
Data Table on Disease Type - Market share 2024-2029 (%)
6.2 Comparison by Disease Type
Chart on Comparison by Disease Type
Data Table on Comparison by Disease Type
6.3 Ulcerative colitis - Market size and forecast 2024-2029
Chart on Ulcerative colitis - Market size and forecast 2024-2029 ($ million)
Data Table on Ulcerative colitis - Market size and forecast 2024-2029 ($ million)
Chart on Ulcerative colitis - Year-over-year growth 2024-2029 (%)
Data Table on Ulcerative colitis - Year-over-year growth 2024-2029 (%)
6.4 Crohns disease - Market size and forecast 2024-2029
Chart on Crohns disease - Market size and forecast 2024-2029 ($ million)
Data Table on Crohns disease - Market size and forecast 2024-2029 ($ million)
Chart on Crohns disease - Year-over-year growth 2024-2029 (%)
Data Table on Crohns disease - Year-over-year growth 2024-2029 (%)
6.5 Market opportunity by Disease Type
Market opportunity by Disease Type ($ million)
Data Table on Market opportunity by Disease Type ($ million)
7 Market Segmentation by Application
7.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
7.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
7.3 Diagnosis assistance - Market size and forecast 2024-2029
Chart on Diagnosis assistance - Market size and forecast 2024-2029 ($ million)
Data Table on Diagnosis assistance - Market size and forecast 2024-2029 ($ million)
Chart on Diagnosis assistance - Year-over-year growth 2024-2029 (%)
Data Table on Diagnosis assistance - Year-over-year growth 2024-2029 (%)
7.4 Treatment optimization - Market size and forecast 2024-2029
Chart on Treatment optimization - Market size and forecast 2024-2029 ($ million)
Data Table on Treatment optimization - Market size and forecast 2024-2029 ($ million)
Chart on Treatment optimization - Year-over-year growth 2024-2029 (%)
Data Table on Treatment optimization - Year-over-year growth 2024-2029 (%)
7.5 Disease monitoring - Market size and forecast 2024-2029
Chart on Disease monitoring - Market size and forecast 2024-2029 ($ million)
Data Table on Disease monitoring - Market size and forecast 2024-2029 ($ million)
Chart on Disease monitoring - Year-over-year growth 2024-2029 (%)
Data Table on Disease monitoring - Year-over-year growth 2024-2029 (%)
7.6 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
8 Market Segmentation by End-user
8.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
8.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
8.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
8.4 Specialty clinics - Market size and forecast 2024-2029
Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
8.5 Diagnostic laboratories - Market size and forecast 2024-2029
Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
8.6 Academic and research institutes - Market size and forecast 2024-2029
Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
9 Customer Landscape
9.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Geographic Landscape
10.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
10.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
10.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
10.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
10.5 APAC - Market size and forecast 2024-2029
Chart on APAC - Market size and forecast 2024-2029 ($ million)
Data Table on APAC - Market size and forecast 2024-2029 ($ million)
Chart on APAC - Year-over-year growth 2024-2029 (%)
Data Table on APAC - Year-over-year growth 2024-2029 (%)
10.6 South America - Market size and forecast 2024-2029
Chart on South America - Market size and forecast 2024-2029 ($ million)
Data Table on South America - Market size and forecast 2024-2029 ($ million)
Chart on South America - Year-over-year growth 2024-2029 (%)
Data Table on South America - Year-over-year growth 2024-2029 (%)
10.7 Middle East and Africa - Market size and forecast 2024-2029
Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
10.8 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
10.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
10.10 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
10.11 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
10.12 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
10.13 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
10.14 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
10.15 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
10.16 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
10.17 Australia - Market size and forecast 2024-2029
Chart on Australia - Market size and forecast 2024-2029 ($ million)
Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Chart on Australia - Year-over-year growth 2024-2029 (%)
Data Table on Australia - Year-over-year growth 2024-2029 (%)
10.18 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
11 Drivers, Challenges, and Opportunity/Restraints
11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
11.4 Market opportunities/restraints
12 Competitive Landscape
12.1 Overview
12.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
12.3 Landscape disruption
Overview on factors of disruption
12.4 Industry risks
Impact of key risks on business
13 Competitive Analysis
13.1 Companies profiled
Companies covered
13.2 Company ranking index
Company ranking index
13.3 Market positioning of companies
Matrix on companies position and classification
13.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
13.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
SWOT
13.6 BenevolentAI
BenevolentAI - Overview
BenevolentAI - Product / Service
BenevolentAI - Key offerings
SWOT
13.7 Dova Health Intelligence Inc.
Dova Health Intelligence Inc. - Overview
Dova Health Intelligence Inc. - Product / Service
Dova Health Intelligence Inc. - Key offerings
SWOT
13.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
13.9 Insilico Medicine
Insilico Medicine - Overview
Insilico Medicine - Product / Service
Insilico Medicine - Key offerings
SWOT
13.10 International Business Machines Corp.
International Business Machines Corp. - Overview
International Business Machines Corp. - Business segments
International Business Machines Corp. - Key news
International Business Machines Corp. - Key offerings
International Business Machines Corp. - Segment focus
SWOT
13.11 Olympus Corp.
Olympus Corp. - Overview
Olympus Corp. - Business segments
Olympus Corp. - Key news
Olympus Corp. - Key offerings
Olympus Corp. - Segment focus
SWOT
13.12 Owkin Inc.
Owkin Inc. - Overview
Owkin Inc. - Product / Service
Owkin Inc. - Key offerings
SWOT
13.13 PathAI Inc.
PathAI Inc. - Overview
PathAI Inc. - Product / Service
PathAI Inc. - Key offerings
SWOT
13.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
13.15 Siemens Healthineers AG
Siemens Healthineers AG - Overview
Siemens Healthineers AG - Business segments
Siemens Healthineers AG - Key news
Siemens Healthineers AG - Key offerings
Siemens Healthineers AG - Segment focus
SWOT
13.16 SingHealth Group.
SingHealth Group. - Overview
SingHealth Group. - Product / Service
SingHealth Group. - Key offerings
SWOT
13.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
13.18 Tempus Labs Inc.
Tempus Labs Inc. - Overview
Tempus Labs Inc. - Product / Service
Tempus Labs Inc. - Key offerings
SWOT
14 Appendix
14.1 Scope of the report
14.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
14.3 Currency conversion rates for US$
Currency conversion rates for US$
14.4 Research methodology
Research methodology
14.5 Data procurement
Information sources
14.6 Data validation
Data validation
14.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
14.8 Data synthesis
Data synthesis
14.9 360 degree market analysis
360 degree market analysis
14.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Five forces analysis - Comparison between 2024 and 2029
Exhibits 26: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 28: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 29: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 30: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 31: Chart on Market condition - Five forces 2024 and 2029
Exhibits 32: Chart on Disease Type - Market share 2024-2029 (%)
Exhibits 33: Data Table on Disease Type - Market share 2024-2029 (%)
Exhibits 34: Chart on Comparison by Disease Type
Exhibits 35: Data Table on Comparison by Disease Type
Exhibits 36: Chart on Ulcerative colitis - Market size and forecast 2024-2029 ($ million)
Exhibits 37: Data Table on Ulcerative colitis - Market size and forecast 2024-2029 ($ million)
Exhibits 38: Chart on Ulcerative colitis - Year-over-year growth 2024-2029 (%)
Exhibits 39: Data Table on Ulcerative colitis - Year-over-year growth 2024-2029 (%)
Exhibits 40: Chart on Crohns disease - Market size and forecast 2024-2029 ($ million)
Exhibits 41: Data Table on Crohns disease - Market size and forecast 2024-2029 ($ million)
Exhibits 42: Chart on Crohns disease - Year-over-year growth 2024-2029 (%)
Exhibits 43: Data Table on Crohns disease - Year-over-year growth 2024-2029 (%)
Exhibits 44: Market opportunity by Disease Type ($ million)
Exhibits 45: Data Table on Market opportunity by Disease Type ($ million)
Exhibits 46: Chart on Application - Market share 2024-2029 (%)
Exhibits 47: Data Table on Application - Market share 2024-2029 (%)
Exhibits 48: Chart on Comparison by Application
Exhibits 49: Data Table on Comparison by Application
Exhibits 50: Chart on Diagnosis assistance - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Diagnosis assistance - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Diagnosis assistance - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Diagnosis assistance - Year-over-year growth 2024-2029 (%)
Exhibits 54: Chart on Treatment optimization - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Data Table on Treatment optimization - Market size and forecast 2024-2029 ($ million)
Exhibits 56: Chart on Treatment optimization - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Treatment optimization - Year-over-year growth 2024-2029 (%)
Exhibits 58: Chart on Disease monitoring - Market size and forecast 2024-2029 ($ million)
Exhibits 59: Data Table on Disease monitoring - Market size and forecast 2024-2029 ($ million)
Exhibits 60: Chart on Disease monitoring - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Disease monitoring - Year-over-year growth 2024-2029 (%)
Exhibits 62: Market opportunity by Application ($ million)
Exhibits 63: Data Table on Market opportunity by Application ($ million)
Exhibits 64: Chart on End-user - Market share 2024-2029 (%)
Exhibits 65: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 66: Chart on Comparison by End-user
Exhibits 67: Data Table on Comparison by End-user
Exhibits 68: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 72: Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 73: Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 74: Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
Exhibits 75: Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
Exhibits 76: Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
Exhibits 77: Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
Exhibits 78: Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Exhibits 79: Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Exhibits 80: Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 81: Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 82: Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Exhibits 83: Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Exhibits 84: Market opportunity by End-user ($ million)
Exhibits 85: Data Table on Market opportunity by End-user ($ million)
Exhibits 86: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 87: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 88: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 89: Chart on Geographic comparison
Exhibits 90: Data Table on Geographic comparison
Exhibits 91: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 93: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 94: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 95: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 97: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 98: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 99: Chart on APAC - Market size and forecast 2024-2029 ($ million)
Exhibits 100: Data Table on APAC - Market size and forecast 2024-2029 ($ million)
Exhibits 101: Chart on APAC - Year-over-year growth 2024-2029 (%)
Exhibits 102: Data Table on APAC - Year-over-year growth 2024-2029 (%)
Exhibits 103: Chart on South America - Market size and forecast 2024-2029 ($ million)
Exhibits 104: Data Table on South America - Market size and forecast 2024-2029 ($ million)
Exhibits 105: Chart on South America - Year-over-year growth 2024-2029 (%)
Exhibits 106: Data Table on South America - Year-over-year growth 2024-2029 (%)
Exhibits 107: Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Exhibits 108: Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Exhibits 109: Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
Exhibits 110: Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
Exhibits 111: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 112: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 113: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 114: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 115: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 116: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 117: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 118: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 119: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 120: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 121: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 122: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 123: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 124: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 125: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 126: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 127: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 128: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 129: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 130: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 131: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 132: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 133: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 134: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 135: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 136: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 137: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 138: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 139: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 140: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 141: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 142: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 143: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 144: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 145: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 146: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 147: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibits 148: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibits 149: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibits 150: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibits 151: Market opportunity By Geographical Landscape ($ million)
Exhibits 152: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 153: Impact of drivers and challenges in 2024 and 2029
Exhibits 154: Overview on criticality of inputs and factors of differentiation
Exhibits 155: Overview on factors of disruption
Exhibits 156: Impact of key risks on business
Exhibits 157: Companies covered
Exhibits 158: Company ranking index
Exhibits 159: Matrix on companies position and classification
Exhibits 160: AbbVie Inc. - Overview
Exhibits 161: AbbVie Inc. - Product / Service
Exhibits 162: AbbVie Inc. - Key news
Exhibits 163: AbbVie Inc. - Key offerings
Exhibits 164: SWOT
Exhibits 165: Bayer AG - Overview
Exhibits 166: Bayer AG - Business segments
Exhibits 167: Bayer AG - Key news
Exhibits 168: Bayer AG - Key offerings
Exhibits 169: Bayer AG - Segment focus
Exhibits 170: SWOT
Exhibits 171: BenevolentAI - Overview
Exhibits 172: BenevolentAI - Product / Service
Exhibits 173: BenevolentAI - Key offerings
Exhibits 174: SWOT
Exhibits 175: Dova Health Intelligence Inc. - Overview
Exhibits 176: Dova Health Intelligence Inc. - Product / Service
Exhibits 177: Dova Health Intelligence Inc. - Key offerings
Exhibits 178: SWOT
Exhibits 179: F. Hoffmann La Roche Ltd. - Overview
Exhibits 180: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 181: F. Hoffmann La Roche Ltd. - Key news
Exhibits 182: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 183: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 184: SWOT
Exhibits 185: Insilico Medicine - Overview
Exhibits 186: Insilico Medicine - Product / Service
Exhibits 187: Insilico Medicine - Key offerings
Exhibits 188: SWOT
Exhibits 189: International Business Machines Corp. - Overview
Exhibits 190: International Business Machines Corp. - Business segments
Exhibits 191: International Business Machines Corp. - Key news
Exhibits 192: International Business Machines Corp. - Key offerings
Exhibits 193: International Business Machines Corp. - Segment focus
Exhibits 194: SWOT
Exhibits 195: Olympus Corp. - Overview
Exhibits 196: Olympus Corp. - Business segments
Exhibits 197: Olympus Corp. - Key news
Exhibits 198: Olympus Corp. - Key offerings
Exhibits 199: Olympus Corp. - Segment focus
Exhibits 200: SWOT
Exhibits 201: Owkin Inc. - Overview
Exhibits 202: Owkin Inc. - Product / Service
Exhibits 203: Owkin Inc. - Key offerings
Exhibits 204: SWOT
Exhibits 205: PathAI Inc. - Overview
Exhibits 206: PathAI Inc. - Product / Service
Exhibits 207: PathAI Inc. - Key offerings
Exhibits 208: SWOT
Exhibits 209: Pfizer Inc. - Overview
Exhibits 210: Pfizer Inc. - Product / Service
Exhibits 211: Pfizer Inc. - Key news
Exhibits 212: Pfizer Inc. - Key offerings
Exhibits 213: SWOT
Exhibits 214: Siemens Healthineers AG - Overview
Exhibits 215: Siemens Healthineers AG - Business segments
Exhibits 216: Siemens Healthineers AG - Key news
Exhibits 217: Siemens Healthineers AG - Key offerings
Exhibits 218: Siemens Healthineers AG - Segment focus
Exhibits 219: SWOT
Exhibits 220: SingHealth Group. - Overview
Exhibits 221: SingHealth Group. - Product / Service
Exhibits 222: SingHealth Group. - Key offerings
Exhibits 223: SWOT
Exhibits 224: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 225: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 226: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 227: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 228: SWOT
Exhibits 229: Tempus Labs Inc. - Overview
Exhibits 230: Tempus Labs Inc. - Product / Service
Exhibits 231: Tempus Labs Inc. - Key offerings
Exhibits 232: SWOT
Exhibits 233: Inclusions checklist
Exhibits 234: Exclusions checklist
Exhibits 235: Currency conversion rates for US$
Exhibits 236: Research methodology
Exhibits 237: Information sources
Exhibits 238: Data validation
Exhibits 239: Validation techniques employed for market sizing
Exhibits 240: Data synthesis
Exhibits 241: 360 degree market analysis
Exhibits 242: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global global AI in inflammatory bowel disease market: AbbVie Inc., Bayer AG, BenevolentAI, Dova Health Intelligence Inc., F. Hoffmann La Roche Ltd., Insilico Medicine, International Business Machines Corp., Olympus Corp., Owkin Inc., PathAI Inc., Pfizer Inc., Siemens Healthineers AG, SingHealth Group., Takeda Pharmaceutical Co. Ltd., and Tempus Labs Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is evolution from diagnostic augmentation to predictive and prognostic intelligence."

According to the report, one of the major drivers for this market is the imperative for enhanced diagnostic accuracy and personalized treatment pathways.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Bayer AG
  • BenevolentAI
  • Dova Health Intelligence Inc.
  • F. Hoffmann La Roche Ltd.
  • Insilico Medicine
  • International Business Machines Corp.
  • Olympus Corp.
  • Owkin Inc.
  • PathAI Inc.
  • Pfizer Inc.
  • Siemens Healthineers AG
  • SingHealth Group.
  • Takeda Pharmaceutical Co. Ltd.
  • Tempus Labs Inc.